Caricamento...
Renal Failure among Multiple Myeloma patients utilizing Carfilzomib and Associated Factors in the ‘Real-World’
BACKGROUND: Carfilzomib, a next generation proteasome inhibitor, improves outcomes in patients with multiple myeloma (MM); however, a proportion of those treated develop renal failure due to adverse event, comorbidity, or myeloma progression. The rate of renal failure and associated risk factors rem...
Salvato in:
| Pubblicato in: | Ann Hematol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054467/ https://ncbi.nlm.nih.gov/pubmed/33475778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-021-04420-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|